Page 15 - NIS English February1-15
P. 15

Interview
                                                                                         Dr V K Paul


                    It takes eight to ten years to make the


                 vaccine in a simple way, but India was in

                                   the lead role to invent it




          The biggest vaccination drive has begun in world’s largest democracy – India. After
         making of the vaccine, prioritising vaccination and protocol, the process of vaccination

          is being managed like a poll booth during the time of elections. Consulting Editor of
        New India Samachar Santosh Kumar spoke to Chairman of the National Expert Group
        on Vaccine Administration of COVID-19 and NITI Aayog Member (Health) Dr V K Paul

                             on the journey of vaccine. Here are some excerpts:
          What was the Government’s initial thought
          process about  dealing  with  such  a  huge
          pandemic and making the vaccine?
          India’s response  has been linked  to science
          and  technology  during  this  pandemic.  In
          the month of April itself, a task force was
          constituted  and  empowered  to  find  scientific
          and  technical  solutions  for  the  vaccine  and
          create suitable facilities for it. Scientists from
          national laboratories and people involved in the
          vaccine industry were encouraged together.
          When  prospects looked bright for the vaccine,
          the Government also provided  resources and
          funds for the same. From the very beginning, the
          goal was to invent and produce vaccines in the
          country itself. We have succeeded and four more
          vaccines are in the trial phase. New vaccines will
          also  come  in  the  future  and  production  of  the
          ready vaccines will increase.

          How challenging was the journey to make              Both our vaccines are completely safe.
          indigenous vaccine?                                     A lot of data is available. We have
          It was challenging but we didn’t have any doubts       experience of testing on thousands
          about capabilities of our scientists. The result is    of people. It is very robust. Through
          in front of everyone.                                  authorisation we have got a chance

          How was such a big infrastructure, especially         to take it forward. We will understand
          the cold chain for the vaccine, created?              more once the results come in for the
          See, India has a long experience of vaccinating      vaccine clinical trials that are currently
          pregnant women and children. Every year over          underway. With the completion of our
          65  Crore vaccines are given  in more than 90         trial, we will move forward with more
          Lakh  sessions.  To  a  large  extent,  cold  chain                understanding.
          facility was there  which was increased  as per


                                                                                  New India Samachar 13
   10   11   12   13   14   15   16   17   18   19   20